Drug Trial Radar · NCT05585606
Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Oct 19, 2022
Primary completion
Sep 15, 2025
Study completion Sep 15, 2025
Sponsor
- Lead sponsor
- Silver Creek PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Conditions
- Acute Ischemic Stroke (AIS)
Interventions
PlaceboDrug
Volume Matched Placebo
scp776 (1.9 mg/kg)Drug
Cohort 1 dose regimen: Intravenous (IV) slow injection(s) over 2 minutes \- 1.9 mg/kg
scp776 (3.8 mg/kg)Drug
Cohort 2 dose regimen: Intravenous (IV) slow injection(s) over 2 minutes \- 3.8 mg/kg
scp776 (4.8 mg/kg)Drug
Cohort 3 dose regimen: Intravenous (IV) slow injection(s) over 2 minutes - 4.8 mg/kg
scp776 (all dose levels)Drug
A composite group encompassing all participants who received any dose level of the investigational drug under evaluation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total number of SAEs recorded prior to hospital dischargeTime frame: Baseline to Day 7 or at hospital discharge (whichever occurs first).
- Proportion of subjects experiencing adverse events of special interest (AESIs)Time frame: Baseline to Day 7 or at hospital discharge (whichever occurs first).
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
HonorHealth Scottsdale Osborn Medical Center
Scottsdale, Arizona
Banner University Medical Center /Univ of Arizona
Tucson, Arizona
Hartford Hospital
Hartford, Connecticut
Marcus Neuroscience Institute
Boca Raton, Florida
University of Miami - Jackson Memorial Hospital
Miami, Florida
Augusta University Medical Center
Augusta, Georgia
SSM Health DePaul Hospital
Bridgeton, Missouri
St. Luke's Hospital of Kansas City
Kansas City, Missouri
UNM Hospital
Albuquerque, New Mexico
Northshore University Hospital
Manhasset, New York
Lennox Hill Hospital
New York, New York
University of Cincinnati
Cincinnati, Ohio
The Ohio State University
Columbus, Ohio
Mercy Health - St Vincent Medical Center
Toledo, Ohio
Mercy Health - St Elizabeth Youngstown Hospital
Youngstown, Ohio
Providence Portland Medical Center
Portland, Oregon
Oregon Stroke Center at OHSU
Portland, Oregon
Providence St. Vincent Medical Center
West Haven-Sylvan, Oregon
Jefferson Abington Hospital
Abington, Pennsylvania
Penn State Health - M.S. Hershey Medical Center
Hershey, Pennsylvania
Houston Methodist Neurological Institute
Houston, Texas
Medical College of Wisconsin and Froedtert Hospital
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.